Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 801-825 of 936 matching filings.

Per page
25
Current page
33
PRE 14A File 000-22873

PRELIMINARY PROXY STATEMENT

Filing date
16 Jan 2013
Reporting date
16 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
03 Jan 2013
Reporting date
03 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-189129

D filing

Filing date
28 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

SCHEDULE 13G

Filing date
28 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
20 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
19 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
12 Dec 2012
Reporting date
12 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-51477

SC 13D

Filing date
02 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
02 Nov 2012
Reporting date
25 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-186357

D filing

Filing date
31 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
24 Oct 2012
Reporting date
22 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
24 Oct 2012
Reporting date
22 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
24 Oct 2012
Reporting date
22 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
24 Oct 2012
Reporting date
22 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
23 Oct 2012
Reporting date
22 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
16 Oct 2012
Reporting date
10 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
17 Aug 2012
Reporting date
15 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

SABBY 13G ABIO 8.08.12

Filing date
08 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-172686

RULE 424(B)(5)

Filing date
03 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
03 Aug 2012
Reporting date
02 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
30 May 2012
Reporting date
25 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
16 Apr 2012
Reporting date
12 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .